Summary – In the world of drug discovery, for the most part, it hasn’t changed much in decades. Ross Youngs, CEO of Biosortia Pharmaceuticals, is looking to change that with a better understanding of the microbiome.

PODCAST: 9/24/2020

(September 24, 2020) | By Ammon Rivera.

Through an interesting turn of events, Biosortia discovered they had access to large amounts of Aquatic Microbiome. With a broad range of capabilities, they are able to extrapolate this into drug discovery. Ross believes that Biosortia’s ability to mine microbiome on such a large scale will change drug discovery in the coming years.

   Apple Podcasts

   Google Podcasts

   Spotify Podcasts